help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrine Reviews, doi:10.1210/edrv-16-3-370
Endocrine Reviews 16 (3): 370-389
Copyright © 1995 by The Endocrine Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CONTI, M.
Right arrow Articles by VICINI, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CONTI, M.
Right arrow Articles by VICINI, E.

Recent Progress in Understanding the Hormonal Regulation of Phosphodiesterases

MARCO CONTI, GEORGES NEMOZ, CLAUDIO SETTE and ELENA VICINI

Department of Gynecology and Obstetrics, Division of Reproductive Biology, Stanford University Medical Center Stanford, California 94305-5317

Correspondence: Address reprint requests to: Marco Conti, M.D., Department of Gynecology and Obstetrics, Division of Reproductive Biology, Stanford University Medical Center, 300 Pasteur Drive, Room A344, Stanford, California 94305-5317.

Abstract

I. Introduction: LAYER after layer of novel regulatory circuits have been added to the map charting the signal transduction pathways that transport information throughout the cell. New components of these pathways are found at a breathtaking pace, and new functions for old components are continuously uncovered. It is now recognized that the complexity of these pathways resembles the intricacy and integration of the pathways of intermediate metabolism. This is especially true for the cyclic nucleotide-dependent signal transduction and its components, including cyclic nucleotide phosphodiesterases (PDEs).These are the enzymes that with cyclases control the intracellular concentration of cyclic nucleotides. With the development of new molecular tools, a wealth of new information has accumulated on the structure and function of these enzymes. Four years ago we reviewed the current knowledge on the mechanisms of hormonal regulation of PDEs (1). Here, we update this survey, reporting the most recent developments of this field. Since our previous review, many primary structures of the human and mammalian PDEs have been elucidated. This has brought about a better understanding of the structure/function relationship of these proteins. Furthermore, PDE gene structure is being actively investigated, adding a further dimension to the regulation of these enzymes and opening new avenues of investigation. Novel mechanisms of regulation have been uncovered, linking these enzymes to new hormone-dependent functions. As we will discuss in detail, the overall picture derived from these findings reinforces the concept that PDEs may serve three major functions in the cell target for hormones and neurotransmitters: 1) They are effectors in signal transduction, 2) they play a role in integrating different signal transduction pathways, and 3) they may also serve as a dampening device to decrease or terminate hormonal stimulation.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. D. Bruss, W. Richter, K. Horner, S.-L. C. Jin, and M. Conti
Critical Role of PDE4D in {beta}2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts
J. Biol. Chem., August 15, 2008; 283(33): 22430 - 22442.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
K. A. Neville, S. J. Szefler, S. M. Abdel-Rahman, G. Lahu, K. Zech, R. Herzog, T. D. Bethke, M. C. Gleason, and G. L. Kearns
Single-Dose Pharmacokinetics of Roflumilast in Children and Adolescents
J. Clin. Pharmacol., August 1, 2008; 48(8): 978 - 985.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, F. Whelan, P. Deloukas, P. Whittaker, M. Delgado, R. M. Cantor, S. M. McCann, and J. Licinio
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response
PNAS, October 10, 2006; 103(41): 15124 - 15129.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Cheng, M. A. Thompson, H. J. Walker, C. E. Gray, G. M. Warner, W. Zhou, and J. P. Grande
Lixazinone stimulates mitogenesis of madin-darby canine kidney cells.
Experimental Biology and Medicine, March 1, 2006; 231(3): 288 - 295.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
S. Wang, G. Wang, B. E. Barton, T. F. Murphy, and H. F. S. Huang
Impaired Sperm Function After Spinal Cord Injury in the Rat Is Associated With Altered Cyclic Adenosine Monophosphate Signaling
J Androl, September 1, 2005; 26(5): 592 - 600.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Seybold, D. Thomas, M. Witzenrath, S. Boral, A. C. Hocke, A. Burger, A. Hatzelmann, H. Tenor, C. Schudt, M. Krull, et al.
Tumor necrosis factor-{alpha}-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability
Blood, May 1, 2005; 105(9): 3569 - 3576.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Xiang, F. Naro, M. Zoudilova, S.-L. C. Jin, M. Conti, and B. Kobilka
Phosphodiesterase 4D is required for {beta}2 adrenoceptor subtype-specific signaling in cardiac myocytes
PNAS, January 18, 2005; 102(3): 909 - 914.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Yoshida, L. Beltran-Parrazal, P. Butler, M. Conti, A. C. Charles, and R. I. Weiner
Lowering Cyclic Adenosine-3',5'-Monophosphate (cAMP) Levels by Expression of a cAMP-Specific Phosphodiesterase Decreases Intrinsic Pulsatile Gonadotropin-Releasing Hormone Secretion from GT1 Cells
Mol. Endocrinol., October 1, 2003; 17(10): 1982 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. H. Maurice, D. Palmer, D. G. Tilley, H. A. Dunkerley, S. J. Netherton, D. R. Raymond, H. S. Elbatarny, and S. L. Jimmo
Cyclic Nucleotide Phosphodiesterase Activity, Expression, and Targeting in Cells of the Cardiovascular System
Mol. Pharmacol., September 1, 2003; 64(3): 533 - 546.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
V. Fournier, P. Leclerc, N. Cormier, and J. L. Bailey
Implication of Calmodulin-Dependent Phosphodiesterase Type 1 During Bovine Sperm Capacitation
J Androl, January 1, 2003; 24(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Oger, C. Mehats, E. Dallot, F. Ferre, and M.-J. Leroy
Interleukin-1{beta} Induces Phosphodiesterase 4B2 Expression in Human Myometrial Cells through a Prostaglandin E2- and Cyclic Adenosine 3',5'-Monophosphate-Dependent Pathway
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5524 - 5531.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Richter and M. Conti
Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)
J. Biol. Chem., October 18, 2002; 277(43): 40212 - 40221.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. R. Le Jeune, M. Shepherd, G. Van Heeke, M. D. Houslay, and I. P. Hall
Cyclic AMP-dependent Transcriptional Up-regulation of Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells. IDENTIFICATION AND CHARACTERIZATION OF A NOVEL PDE4D5 PROMOTER
J. Biol. Chem., September 20, 2002; 277(39): 35980 - 35989.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. J. Chiu and I. A. Reid
Effect of Sildenafil on Renin Secretion in Human Subjects
Experimental Biology and Medicine, September 1, 2002; 227(8): 620 - 625.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Mehats, G. Tanguy, E. Dallot, D. Cabrol, F. Ferre, and M.-J. Leroy
Is Up-Regulation of Phosphodiesterase 4 Activity by PGE2 Involved in the Desensitization of {beta}-Mimetics in Late Pregnancy Human Myometrium?
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5358 - 5365.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Persani, S. Borgato, A. Lania, M. Filopanti, G. Mantovani, M. Conti, and A. Spada
Relevant cAMP-Specific Phosphodiesterase Isoforms in Human Pituitary: Effect of Gs{alpha} Mutations
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3795 - 3800.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. T. Schermuly, N. Weissmann, B. Enke, H. A. Ghofrani, W. G. Forssmann, F. Grimminger, W. Seeger, and D. Walmrath
Urodilatin, a Natriuretic Peptide Stimulating Particulate Guanylate Cyclase, and the Phosphodiesterase 5 Inhibitor Dipyridamole Attenuate Experimental Pulmonary Hypertension . Synergism upon Coapplication
Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 219 - 225.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. C. Rich, T. E. Tse, J. G. Rohan, J. Schaack, and J. W. Karpen
In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide-Gated Channels as Camp Sensors
J. Gen. Physiol., July 1, 2001; 118(1): 63 - 78.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
P. F. Pollice, R. N. Rosier, R. J. Looney, J. E. Puzas, E. M. Schwarz, and R. J. O'Keefe
Oral Pentoxifylline Inhibits Release of Tumor Necrosis Factor-Alpha from Human Peripheral Blood Monocytes : A Potential Treatment for Aseptic Loosening of Total Joint Components
J. Bone Joint Surg. Am., July 1, 2001; 83(7): 1057 - 1061.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. A. Piazza, W. J. Thompson, R. Pamukcu, H. W. Alila, C. M. Whitehead, L. Liu, J. R. Fetter, W. E. Gresh Jr., A. J. Klein-Szanto, D. R. Farnell, et al.
Exisulind, a Novel Proapoptotic Drug, Inhibits Rat Urinary Bladder Tumorigenesis
Cancer Res., May 1, 2001; 61(10): 3961 - 3968.
[Abstract] [Full Text]


Home page
DevelopmentHome page
S. Stricker and T. Smythe
5-HT causes an increase in cAMP that stimulates, rather than inhibits, oocyte maturation in marine nemertean worms
Development, January 4, 2001; 128(8): 1415 - 1427.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
M. Conti
Phosphodiesterases and Cyclic Nucleotide Signaling in Endocrine Cells
Mol. Endocrinol., September 1, 2000; 14(9): 1317 - 1327.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Persani, A. Lania, L. Alberti, R. Romoli, G. Mantovani, S. Filetti, A. Spada, and M. Conti
Induction of Specific Phosphodiesterase Isoforms by Constitutive Activation of the cAMP Pathway in Autonomous Thyroid Adenomas
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2872 - 2878.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Hansen, S.-L. C. Jin, D. T. Umetsu, and M. Conti
Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D
PNAS, June 6, 2000; 97(12): 6751 - 6756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. MacKenzie, G. S. Baillie, I. McPhee, G. B. Bolger, and M. D. Houslay
ERK2 Mitogen-activated Protein Kinase Binding, Phosphorylation, and Regulation of the PDE4D cAMP-specific Phosphodiesterases. THE INVOLVEMENT OF COOH-TERMINAL DOCKING SITES AND NH2-TERMINAL UCR REGIONS
J. Biol. Chem., May 26, 2000; 275(22): 16609 - 16617.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ahmad, L.-N. Cong, L. Stenson Holst, L.-M. Wang, T. Rahn Landstrom, J. H. Pierce, M. J. Quon, E. Degerman, and V. C. Manganiello
Cyclic Nucleotide Phosphodiesterase 3B Is a Downstream Target of Protein Kinase B and May Be Involved in Regulation of Effects of Protein Kinase B on Thymidine Incorporation in FDCP2 Cells
J. Immunol., May 1, 2000; 164(9): 4678 - 4688.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Oki, S.-I. Takahashi, H. Hidaka, and M. Conti
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION
J. Biol. Chem., April 6, 2000; 275(15): 10831 - 10837.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, C. Schudt, H. Tenor, F. Grimminger, W. Seeger, and D. Walmrath
Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 512 - 520.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Méhats, G. Tanguy, B. Paris, B. Robert, N. Pernin, F. Ferré, and M.-J. Leroy
Pregnancy Induces a Modulation of the cAMP Phosphodiesterase 4-Conformers Ratio in Human Myometrium: Consequences for the Utero-Relaxant Effect of PDE4-Selective Inhibitors
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 817 - 823.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
A. Aversa, F. Mazzilli, T. Rossi, M. Delfino, A. M. Isidori, and A. Fabbri
Effects of sildenafil (ViagraTM) administration on seminal parameters and post-ejaculatory refractory time in normal males
Hum. Reprod., January 1, 2000; 15(1): 131 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Fink, S. H. Francis, A. Beasley, K. A. Grimes, and J. D. Corbin
Expression of an Active, Monomeric Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5)
J. Biol. Chem., December 3, 1999; 274(49): 34613 - 34620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Naro, C. Sette, E. Vicini, V. De Arcangelis, M. Grange, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, and G. Némoz
Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells
Mol. Biol. Cell, December 1, 1999; 10(12): 4355 - 4367.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. T. SCHERMULY, H. A. GHOFRANI, B. ENKE, N. WEISSMANN, F. GRIMMINGER, W. SEEGER, C. SCHUDT, and D. WALMRATH
Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1500 - 1506.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-L. C. Jin, F. J. Richard, W.-P. Kuo, A. J. D'Ercole, and M. Conti
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
PNAS, October 12, 1999; 96(21): 11998 - 12003.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
I. J. Gonzalez-Robayna, T. N. Alliston, P. Buse, G. L. Firestone, and J. S. Richards
Functional and Subcellular Changes in the A-Kinase-Signaling Pathway: Relation to Aromatase and Sgk Expression during the Transition of Granulosa Cells to Luteal Cells
Mol. Endocrinol., August 1, 1999; 13(8): 1318 - 1337.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
W. Richter, D. Dettmer, and H.-J. Glander
Detection of mRNA transcripts of cyclic nucleotide phosphodiesterase subtypes in ejaculated human spermatozoa
Mol. Hum. Reprod., August 1, 1999; 5(8): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Côté, M. D. Payet, E. Rousseau, G. Guillon, and N. Gallo-Payet
Comparative Involvement of Cyclic Nucleotide Phosphodiesterases and Adenylyl Cyclase on Adrenocorticotropin-Induced Increase of Cyclic Adenosine Monophosphate in Rat and Human Glomerulosa Cells
Endocrinology, August 1, 1999; 140(8): 3594 - 3601.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Lim, G. Pahlke, and M. Conti
Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation. IDENTIFICATION AND FUNCTION OF AN INHIBITORY DOMAIN
J. Biol. Chem., July 9, 1999; 274(28): 19677 - 19685.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. J. Chiu, S.-H. Hu, and I. A. Reid
Inhibition of Phosphodiesterase III with Milrinone Increases Renin Secretion in Human Subjects
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 16 - 19.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Méhats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet, F. Ferré, and M. J. Leroy
Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture
Endocrinology, July 1, 1999; 140(7): 3228 - 3237.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. D. Corbin and S. H. Francis
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil
J. Biol. Chem., May 14, 1999; 274(20): 13729 - 13732.
[Full Text] [PDF]


Home page
EndocrinologyHome page
M. Salanova, S.-Y. Chun, S. Iona, C. Puri, M. Stefanini, and M. Conti
Type 4 Cyclic Adenosine Monophosphate-Specific Phosphodiesterases Are Expressed in Discrete Subcellular Compartments during Rat Spermiogenesis
Endocrinology, May 1, 1999; 140(5): 2297 - 2306.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
I. McPhee, S. J. Yarwood, G. Scotland, E. Huston, M. B. Beard, A. H. Ross, E. S. Houslay, and M. D. Houslay
Association with the SRC Family Tyrosyl Kinase LYN Triggers a Conformational Change in the Catalytic Region of Human cAMP-specific Phosphodiesterase HSPDE4A4B. CONSEQUENCES FOR ROLIPRAM INHIBITION
J. Biol. Chem., April 23, 1999; 274(17): 11796 - 11810.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Ahmad, G. Gao, L. M. Wang, T. R. Landstrom, E. Degerman, J. H. Pierce, and V. C. Manganiello
IL-3 and IL-4 Activate Cyclic Nucleotide Phosphodiesterases 3 (PDE3) and 4 (PDE4) by Different Mechanisms in FDCP2 Myeloid Cells
J. Immunol., April 15, 1999; 162(8): 4864 - 4875.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Ibrahimi, N. Abumrad, H. Maghareie, M. Golia, I. Shoshani, L. Desaubry, and R. A. Johnson
Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes
Am J Physiol Cell Physiol, February 1, 1999; 276(2): C487 - C496.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Takahashi, R. Terwilliger, C. Lane, P. S. Mezes, M. Conti, and R. S. Duman
Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms
J. Neurosci., January 15, 1999; 19(2): 610 - 618.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. Ma, S. Wera, P. Van Dijck, and J. M. Thevelein
The PDE1-encoded Low-Affinity Phosphodiesterase in the Yeast Saccharomyces cerevisiae Has a Specific Function in Controlling Agonist-induced cAMP Signaling
Mol. Biol. Cell, January 1, 1999; 10(1): 91 - 104.
[Abstract] [Full Text]


Home page
JCBHome page
K. L. O'Connor, L. M. Shaw, and A. M. Mercurio
Release of cAMP Gating by the {alpha}6{beta}4 Integrin Stimulates Lamellae Formation and the Chemotactic Migration of Invasive Carcinoma Cells
J. Cell Biol., December 14, 1998; 143(6): 1749 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. A. Antoni, M. Palkovits, J. Simpson, S. M. Smith, A. L. Leitch, R. Rosie, G. Fink, and J. M. Paterson
Ca2+/Calcineurin-Inhibited Adenylyl Cyclase, Highly Abundant in Forebrain Regions, Is Important for Learning and Memory
J. Neurosci., December 1, 1998; 18(23): 9650 - 9661.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Seybold, R. Newton, L. Wright, P. A. Finney, N. Suttorp, P. J. Barnes, I. M. Adcock, and M. A. Giembycz
Induction of Phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in Human Peripheral Blood T-lymphocytes by 8-Bromo-cAMP and Gs-coupled Receptor Agonists. POTENTIAL ROLE IN beta 2-ADRENORECEPTOR DESENSITIZATION
J. Biol. Chem., August 7, 1998; 273(32): 20575 - 20588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. M. Moore, P. M. Chetham, J. J. Kelly, and T. Stevens
Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP
Am J Physiol Lung Cell Mol Physiol, August 1, 1998; 275(2): L203 - L222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-L. C. Jin, T. Bushnik, L. Lan, and M. Conti
Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases. DIFFERENTIAL TARGETING AND ACTIVATION OF THE SPLICING VARIANTS DERIVED FROM THE PDE4D GENE
J. Biol. Chem., July 31, 1998; 273(31): 19672 - 19678.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Lania, L. Persani, E. Ballaré, S. Mantovani, M. Losa, and A. Spada
Constitutively Active Gs{alpha} Is Associated with an Increased Phosphodiesterase Activity in Human Growth Hormone-Secreting Adenomas
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1624 - 1628.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. J. MacKenzie, S. J. Yarwood, A. H. Peden, G. B. Bolger, R. G. Vernon, and M. D. Houslay
Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes
PNAS, March 31, 1998; 95(7): 3549 - 3554.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Iona, M. Cuomo, T. Bushnik, F. Naro, C. Sette, M. Hess, E. R. Shelton, and M. Conti
Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain
Mol. Pharmacol., January 1, 1998; 53(1): 23 - 32.
[Abstract] [Full Text]


Home page
CirculationHome page
C. J. Smith, R. Huang, D. Sun, S. Ricketts, C. Hoegler, J.-Z. Ding, R. A. Moggio, and T. H. Hintze
Development of Decompensated Dilated Cardiomyopathy Is Associated With Decreased Gene Expression and Activity of the Milrinone-Sensitive cAMP Phosphodiesterase PDE3A
Circulation, November 4, 1997; 96(9): 3116 - 3123.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. S. Wagner, C. J. Smith, A. M. Taylor, and R. A. Rhoades
Phosphodiesterase Inhibition Improves Agonist-Induced Relaxation of Hypertensive Pulmonary Arteries
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1650 - 1657.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
M. Lamas and P. Sassone-Corsi
The Dynamics of the Transcriptional Response to Cyclic Adenosine 3',5'-Monophosphate: Recurrent Inducibility and Refractory Phase
Mol. Endocrinol., September 1, 1997; 11(10): 1415 - 1424.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
E. Vicini and M. Conti
Characterization of an Intronic Promoter of a Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Gene that Confers Hormone and cAMP Inducibility
Mol. Endocrinol., June 1, 1997; 11(7): 839 - 850.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. C.S. Chini, J. P. Grande, E. N. Chini, and T. P. Dousa
Compartmentalization of cAMP Signaling in Mesangial Cells by Phosphodiesterase Isozymes PDE3 and PDE4. REGULATION OF SUPEROXIDATION AND MITOGENESIS
J. Biol. Chem., April 11, 1997; 272(15): 9854 - 9859.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. Juilfs, H.-J. Fulle, A. Z. Zhao, M. D. Houslay, D. L. Garbers, and J. A. Beavo
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway
PNAS, April 1, 1997; 94(7): 3388 - 3395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Degerman, P. Belfrage, and V. C. Manganiello
Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)
J. Biol. Chem., March 14, 1997; 272(11): 6823 - 6826.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Cheng, J. W. Watson, C. J. Pazoles, J. D. Eskra, R. J. Griffiths, V. L. Cohan, C. R. Turner, H. J. Showell, and E. R. Pettipher
The Phosphodiesterase Type 4 (PDE4) Inhibitor CP-80,633 Elevates Plasma Cyclic AMP Levels and Decreases Tumor Necrosis Factor-alpha (TNFalpha ) Production in Mice: Effect of Adrenalectomy
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 621 - 626.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. J. TORPHY
Phosphodiesterase Isozymes . Molecular Targets for Novel Antiasthma Agents
Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 351 - 370.
[Full Text]


Home page
Mol. Pharmacol.Home page
G. Nemoz, C. Sette, and M. Conti
Selective Activation of Rolipram-Sensitive, cAMP-Specific Phosphodiesterase Isoforms by Phosphatidic Acid
Mol. Pharmacol., February 1, 1997; 51(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Poteet-Smith, J. B. Shabb, S. H. Francis, and J. D. Corbin
Identification of Critical Determinants for Autoinhibition in the Pseudosubstrate Region of Type Ialpha cAMP-dependent Protein Kinase
J. Biol. Chem., January 3, 1997; 272(1): 379 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Huston, L. Pooley, P. Julien, G. Scotland, I. McPhee, M. Sullivan, G. Bolger, and M. D. Houslay
The Human Cyclic AMP-specific Phosphodiesterase PDE-46 (HSPDE4A4B) Expressed in Transfected COS7 Cells Occurs as Both Particulate and Cytosolic Species That Exhibit Distinct Kinetics of Inhibition by the Antidepressant Rolipram
J. Biol. Chem., December 6, 1996; 271(49): 31334 - 31344.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Sette and M. Conti
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase. INVOLVEMENT OF SERINE 54IN THE ENZYME ACTIVATION
J. Biol. Chem., July 12, 1996; 271(28): 16526 - 16534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Smith, G. Scotland, J. Beattie, I. P. Trayer, and M. D. Houslay
Determination of the Structure of the N-terminal Splice Region of the Cyclic AMP-specific Phosphodiesterase RD1 (RNPDE4A1) by 1H NMR and Identification of the Membrane Association Domain Using Chimeric Constructs
J. Biol. Chem., July 12, 1996; 271(28): 16703 - 16711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Grange, C. Sette, M. Cuomo, M. Conti, M. Lagarde, A.-F. Prigent, and G. Nemoz
The cAMP-specific Phosphodiesterase PDE4D3 Is Regulated by Phosphatidic Acid Binding. CONSEQUENCES FOR cAMP SIGNALING PATHWAY AND CHARACTERIZATION OF A PHOSPHATIDIC ACID BINDING SITE
J. Biol. Chem., October 20, 2000; 275(43): 33379 - 33387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S.-L. C. Jin, and M. Conti
Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase
J. Biol. Chem., March 30, 2001; 276(14): 11189 - 11198.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Huston, M. Beard, F. McCallum, N. J. Pyne, P. Vandenabeele, G. Scotland, and M. D. Houslay
The cAMP-specific Phosphodiesterase PDE4A5 Is Cleaved Downstream of Its SH3 Interaction Domain by Caspase-3. CONSEQUENCES FOR ALTERED INTRACELLULAR DISTRIBUTION
J. Biol. Chem., September 1, 2000; 275(36): 28063 - 28074.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. C. Rich, K. A. Fagan, T. E. Tse, J. Schaack, D. M. F. Cooper, and J. W. Karpen
A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell
PNAS, November 6, 2001; 98(23): 13049 - 13054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society